CORONA Remedies Ltd.

We are an India-focused branded pharmaceutical formulation company engaged in developing, manufacturingand marketing products in women’s healthcare, cardio-diabeto, pain management, urology and other therapeuticareas. According to the Industry Report, we are the second fastest growing company among the top 30 companiesin the Indian Pharmaceutical Market (“IPM”) in terms of domestic sales between MAT December 2021 and MAT December 2024. During this period, our domestic sales grew at a CAGR of 19.90%, compared to the IPM whichgrew at a CAGR of 8.79%, displaying a growth of more than 2.25 times the IPM’s growth (Source: IndustryReport). This has been driven by our growth in volume (at an average of 9.58% over the above period, comparedto the IPM’s growth of 1.65%), and new product launches (at an average of 3.91% over the above period,compared to the IPM’s growth of 1.68%)